Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial

BACKGROUND: Cardiovascular calcifications are prevented by matrix Gla protein (MGP), a vitamin K–dependent protein. Haemodialysis patients exhibit marked vitamin K deficiency. The randomized, prospective, open-label, multicentre VitaVasK trial analysed whether vitamin K1 supplementation reduces prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Saritas, Turgay, Reinartz, Sebastian, Krüger, Thilo, Ketteler, Markus, Liangos, Orfeas, Labriola, Laura, Stenvinkel, Peter, Kopp, Christoph, Westenfeld, Ralf, Evenepoel, Pieter, Siepmann, Robert, Wied, Stephanie, Hilgers, Ralf-Dieter, Schurgers, Leon, Floege, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664584/
https://www.ncbi.nlm.nih.gov/pubmed/37216675
http://dx.doi.org/10.1093/ckj/sfac184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664584/
https://www.ncbi.nlm.nih.gov/pubmed/37216675
http://dx.doi.org/10.1093/ckj/sfac184

Ejemplares similares